Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Serum beta 2-microglobulin in systemic sclerosis.

L Pagano, S Paoletti, G Afa

    Clinical Rheumatology
    |September 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Exploring the short linear motif-mediated protein-protein interactions of CrkL through ProP-PD.

    Biochemical and biophysical research communications·2024
    Same author

    Liposomal amphotericin B-the present.

    The Journal of antimicrobial chemotherapy·2022
    Same author

    SARS-CoV-2 Infection In Patients With Mastocytosis: An EPICOVIDEHA Report.

    Journal of investigational allergology & clinical immunology·2022
    Same author

    Thyroid function in the subacute phase of traumatic brain injury: a potential predictor of post-traumatic neurological and functional outcomes.

    Journal of endocrinological investigation·2021
    Same author

    Host immune genetic variations influence the risk of developing acute myeloid leukaemia: results from the NuCLEAR consortium.

    Blood cancer journal·2020
    Same author

    Role of Stenotrophomonas maltophilia isolation in patients with non-CF bronchiectasis.

    QJM : monthly journal of the Association of Physicians·2020
    Same journal

    Serum ferritin as a predictor of major adverse cardiovascular events in Takayasu arteritis: a two-center retrospective cohort study.

    Clinical rheumatology·2026
    Same journal

    Inverse association between metabolic dysfunction-associated steatotic liver disease and incident rheumatoid arthritis in middle-aged adults with chronic hepatitis B.

    Clinical rheumatology·2026
    Same journal

    Extension of cytokines' role in Behcet's disease associated peripheral neuropathy.

    Clinical rheumatology·2026
    Same journal

    Renal osteodystrophy with near-complete bilateral sacroiliac ankylosis: a bat-like pelvic configuration on CT.

    Clinical rheumatology·2026
    Same journal

    Serum exosomal tRNA-derived small RNAs as diagnostic biomarkers for primary Sjögren's syndrome: a combined model with autoantibodies.

    Clinical rheumatology·2026
    Same journal

    Monosodium urate crystals induce lytic macrophage death partially dependent on both pyroptosis and necroptosis.

    Clinical rheumatology·2026
    See all related articles

    Beta 2 microglobulin (beta 2-m) levels were elevated in a significant portion of Systemic Sclerosis patients. This suggests beta 2-m may serve as a useful marker for disease activity in Systemic Sclerosis.

    Area of Science:

    • Rheumatology
    • Immunology
    • Biochemistry

    Background:

    • Systemic Sclerosis (SS) is a chronic autoimmune disease characterized by fibrosis.
    • Beta 2 microglobulin (beta 2-m) is a protein found on the surface of most nucleated cells.
    • The role of beta 2-m in the pathogenesis and inflammatory activity of SS requires further elucidation.

    Purpose of the Study:

    • To investigate the levels of beta 2 microglobulin (beta 2-m) in patients with Systemic Sclerosis (SS).
    • To evaluate the potential of beta 2-m as an indicator of inflammatory activity in SS.

    Main Methods:

    • A cohort of 24 female patients with Systemic Sclerosis was studied.
    • Patients were categorized into acrosclerosis (n=15) and diffuse sclerosis (n=9) groups.
    • Serum beta 2-m levels were measured and compared to normal controls.

    Related Experiment Videos

    Main Results:

    • Elevated beta 2-m levels were observed in 46.6% of acrosclerosis patients (p<0.01).
    • Elevated beta 2-m levels were observed in 44.4% of diffuse sclerosis patients (p<0.005).
    • These findings indicate a significant increase in beta 2-m in a substantial proportion of SS patients.

    Conclusions:

    • Beta 2 microglobulin (beta 2-m) levels are significantly elevated in a considerable number of Systemic Sclerosis (SS) patients.
    • Beta 2 microglobulin (beta 2-m) shows potential as a biomarker for assessing inflammatory activity in SS.
    • Further research is warranted to confirm the utility of beta 2-m in monitoring SS progression and treatment response.